RetiSpec, Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
Companies aim to expedite the commercialization of technology designed to…
Read moreCompanies aim to expedite the commercialization of technology designed to…
Read more
TOKYO, Japan – Topcon Corporation (TSE 7732), a leading provider…
Read more
Conditions like retinoschisis, which were mostly invisible to us before,…
Read more
TEMPO’s 24-2 Threshold test can assess the visual field of…
Read more
Investing in the proper tools at the outset will allow…
Read more
Maximizing the advantages of having one trusted partner for all…
Read more
Don't miss out on this year's Vision Expo East events…
Read moreBackground: 33-year-old Caucasian female with history of myopia...
Read moreTEMPO is the novel, binocular approach that makes testing faster…
Read more